by Jonathan Latham, PhD One of the central issues of our day is how to safely manage the outputs of industrial innovation. Novel products incorporating nanotechnology, biotechnology, rare metals, microwaves, novel chemicals, and more, enter ...
Monsanto announced last week that it licensed the CRISPR-Cas9 gene-editing tool from the Broad Institute in Boston for use in seed development. The technology will allow the agritech giant to edit crops’ DNA by “snipping” away undesirable traits – or adding in more desirable ones – of the plants’ genetic codes. Frankenfood? [1]
Source: Business Insider
